You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Prime European Therapeuticals SpA (Add-on Acquistion, in 2016)

Transaction #90532
Investors
3
Sign up to view
Target Company
Prime European Therapeuticals SpA
Life Science · Italy
Seller
1
Sign up to view
358 USD
Deal Value
05 May 2016
Announced
Target Company
Company Sector Entity Type Status State Country
Prime European Therapeuticals SpA Life Science Private Active — Italy
Investors 3
InvestorInvestment TypeAmount% Holding
View 3 Investors
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Prime European Therapeuticals SpA acquisition deal?
This transaction is an acquisition of Prime European Therapeuticals SpA (Add-on Acquistion) in 2016. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Prime European Therapeuticals SpA acquisition happen?
This transaction was announced on 05 May 2016.
What is the deal value of the Prime European Therapeuticals SpA acquisition?
The deal value for this transaction is 358 USD.
Who are the investors in the Prime European Therapeuticals SpA transaction?
This transaction has 3 investors. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Prime European Therapeuticals SpA deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial